[HTML][HTML] Effect of pulmonary rehabilitation for patients with post-COVID-19: a systematic review and meta-analysis
H Chen, H Shi, X Liu, T Sun, J Wu, Z Liu - Frontiers in medicine, 2022 - frontiersin.org
Background: evidences increasingly suggested that impaired respiratory function remained
in about 40% of Coronavirus disease 2019 (COVID-19) patients after discharge …
in about 40% of Coronavirus disease 2019 (COVID-19) patients after discharge …
Pulmonary rehabilitation for interstitial lung disease
L Dowman, CJ Hill, A May… - Cochrane database of …, 2021 - cochranelibrary.com
Background Interstitial lung disease (ILD) is characterised by reduced functional capacity,
dyspnoea and exercise‐induced hypoxia. Pulmonary rehabilitation is often used to improve …
dyspnoea and exercise‐induced hypoxia. Pulmonary rehabilitation is often used to improve …
An official American Thoracic Society/European Respiratory Society policy statement: enhancing implementation, use, and delivery of pulmonary rehabilitation
CL Rochester, I Vogiatzis, AE Holland… - American journal of …, 2015 - atsjournals.org
Rationale: Pulmonary rehabilitation (PR) has demonstrated physiological, symptom-
reducing, psychosocial, and health economic benefits for patients with chronic respiratory …
reducing, psychosocial, and health economic benefits for patients with chronic respiratory …
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation
MA Spruit, SJ Singh, C Garvey… - American journal of …, 2013 - atsjournals.org
Background: Pulmonary rehabilitation is recognized as a core component of the
management of individuals with chronic respiratory disease. Since the 2006 American …
management of individuals with chronic respiratory disease. Since the 2006 American …
Recommendations for hospital-based physical therapists managing patients with COVID-19
KM Felten-Barentsz, R van Oorsouw, E Klooster… - Physical …, 2020 - academic.oup.com
Objective The COVID-19 pandemic is rapidly evolving and has led to increased numbers of
hospitalizations worldwide. Hospitalized patients with COVID-19 experience a variety of …
hospitalizations worldwide. Hospitalized patients with COVID-19 experience a variety of …
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea
MB Parshall, RM Schwartzstein, L Adams… - American journal of …, 2012 - atsjournals.org
Background: Dyspnea is a common, distressing symptom of cardiopulmonary and
neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in …
neuromuscular diseases. Since the ATS published a consensus statement on dyspnea in …
British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE
CE Bolton, EF Bevan-Smith, JD Blakey, P Crowe… - Thorax, 2013 - thorax.bmj.com
Aim Pulmonary rehabilitation has established itself as a key management strategy in people
with chronic respiratory disease. The role of pulmonary rehabilitation has recently been …
with chronic respiratory disease. The role of pulmonary rehabilitation has recently been …
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study
E Fan, DW Dowdy, E Colantuoni… - Critical care …, 2014 - journals.lww.com
Objective: Survivors of severe critical illness frequently develop substantial and persistent
physical complications, including muscle weakness, impaired physical function, and …
physical complications, including muscle weakness, impaired physical function, and …
Acute exacerbation of COPD
FW Ko, KP Chan, DS Hui, JR Goddard, JG Shaw… - …, 2016 - Wiley Online Library
The literature of acute exacerbation of chronic obstructive pulmonary disease (COPD) is fast
expanding. This review focuses on several aspects of acute exacerbation of COPD …
expanding. This review focuses on several aspects of acute exacerbation of COPD …
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a …
JA Wedzicha, M Decramer, JH Ficker… - The lancet Respiratory …, 2013 - thelancet.com
Background We evaluated the effect of dual, longacting inhaled bronchodilator treatment on
exacerbations in patients with severe and very severe chronic obstructive pulmonary …
exacerbations in patients with severe and very severe chronic obstructive pulmonary …